Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) classified as a growth hormone secretagogue receptor (GHSR) agonist that selectively targets the ghrelin receptor
If considering a dose reduction for maintenance: Wait until weight has stabilized for at least 4 weeks at your current dose Reduce by one dose step (e.g., 12mg to 8mg), do not jump multiple steps Monitor weight closely for 8 weeks after the reduction If weight begins to increase, return to the previous maintenance dose The phase 3 trials specifically tested 4mg as a maintenance dose, suggesting Lilly sees viability in lower maintenance doses What happens if you stop Weight regain after discontinuing GLP-1 agonists is well documented with semaglutide and tirzepatide
Everything was neatly organized, with clear instructions on how to do the injections safely
From Orforglipron and Retatrutide to CGM and Teplizumab, the future is already taking shape
For a 5mg vial, 2.5mL creates a 2mg/mL concentration
US$ 25.87
US$ 28.81
US$ 26.20
US$ 25.66
)
